Dr. Thomas Brzoska, Managing Director of PRO-LIANCE GLOBAL SOLUTIONS GmbH, provides strategic leadership in regulatory affairs for advanced medical therapies and medical products.With deep experience in navigating complex approval frameworks, he ensures that CAR-T innovations within the EASYGEN Consortium meet the highest regulatory, safety, and quality standards.As part of the consortium, Pro-Liance brings its regulatory and clinical expertise to the forefront of CAR-T innovation.Through work package 5, developing a regulatory compliance strategy, the team leads the development of a clear regulatory strategy for decentralized CAR-T manufacturing — simplifying processes and reducing administrative workload in hospitals.By streamlining compliance pathways, Pro-Liance is paving the way for faster, safer, and more equitable access to cell and gene therapies across Europe.Collaboration. Innovation. Access.That’s what EASYGEN — and its partners like Pro-Liance — stand for.#RegulatoryAffairs #CART #Innovation #PatientAccess